Insulin Pump During Exercise: Difference between revisions
Ahmed M Diab (talk | contribs) No edit summary |
Ahmed M Diab (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
</div> | </div> | ||
== Introduction == | == Introduction == | ||
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is one of the most significant advances in diabetes technology in the last 50 years. Although the first commercial insulin pumps were available in the 1970s, rapid adoption of insulin pump technology did not occur until the early 2000s, following the completion of the landmark Diabetes Control and Complications Trial (DCCT) in the early 1990s. The DCCT established the value of intensive insulin therapy in maintaining tight glycemic control and preventing diabetic complications such as retinopathy, neuropathy, nephropathy, and cardiovascular disease. <ref>Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy. Diabetes Spectrum. 2019 Aug 1;32(3):194-204.</ref> | |||
Insulin pump therapy, known as continuous subcutaneous insulin infusion (CSII) therapy, makes the hormonal and metabolic responses to exercise nearly normal for patients with type 1 diabetes mellitus ( and some individuals with insulin-requiring type 2 diabetes mellitus). | Insulin pump therapy, known as continuous subcutaneous insulin infusion (CSII) therapy, makes the hormonal and metabolic responses to exercise nearly normal for patients with type 1 diabetes mellitus ( and some individuals with insulin-requiring type 2 diabetes mellitus). | ||
| Line 29: | Line 31: | ||
== References == | == References == | ||
<references /> | <references /> | ||
Revision as of 21:52, 6 December 2022
Original Editor - User Name
Top Contributors - Ahmed M Diab and Aminat Abolade
Introduction[edit | edit source]
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is one of the most significant advances in diabetes technology in the last 50 years. Although the first commercial insulin pumps were available in the 1970s, rapid adoption of insulin pump technology did not occur until the early 2000s, following the completion of the landmark Diabetes Control and Complications Trial (DCCT) in the early 1990s. The DCCT established the value of intensive insulin therapy in maintaining tight glycemic control and preventing diabetic complications such as retinopathy, neuropathy, nephropathy, and cardiovascular disease. [1]
Insulin pump therapy, known as continuous subcutaneous insulin infusion (CSII) therapy, makes the hormonal and metabolic responses to exercise nearly normal for patients with type 1 diabetes mellitus ( and some individuals with insulin-requiring type 2 diabetes mellitus).
Glucose control for type 1 Diabetes mellitus patients is a difficult task with exercise, with a risk of hypoglycemia during the exercise and after it.
Pump use carries many pros for individuals with diabetes who are physically active. However, it may come with a few disadvantages.
Pros for using insulin pump[edit | edit source]
- Insulin pump therapy allows for more precise and flexible insulin dosing with fewer injections. Many individuals with type 1 diabetes mellitus report using insulin pump because they want improved glycemic control and a more flexible lifestyle.
- Many studies and systemic reviews have demonstrated improved glycemic control and a reduction in hypoglycemia with insulin pump therapy in pediatric and adult populations with type 1 diabetes.
- Parental satisfaction with insulin therapy is high.
- Many advantages to managing unpredictable eating habits and low insulin requirements in the youngest children suggesting that insulin pump therapy may be an ideal option for many young children with type 1 diabetes and their families.
Sub Heading 3[edit | edit source]
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
References[edit | edit source]
- ↑ Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy. Diabetes Spectrum. 2019 Aug 1;32(3):194-204.
